MedPath

扬子江药业集团广州海瑞药业有限公司

Ownership
-
Established
2004-04-19
Employees
-
Market Cap
-
Website
www.hairuiyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

27

NMPA:27

Drug Approvals

Gadobutrol Injection

Product Name
钆布醇注射液
Approval Number
国药准字H20244936
Approval Date
Sep 19, 2024
NMPA

Polyethylene Glycol Electrolytes Powder(Ⅲ)

Product Name
复方聚乙二醇电解质散(Ⅲ)
Approval Number
国药准字H20244813
Approval Date
Sep 3, 2024
NMPA

Carboprost Tromethamine Injection

Product Name
卡前列素氨丁三醇注射液
Approval Number
国药准字H20244516
Approval Date
Jul 30, 2024
NMPA

Argatroban Injection

Product Name
阿加曲班注射液
Approval Number
国药准字H20243825
Approval Date
May 28, 2024
NMPA

Gadobutrol Injection

Product Name
钆布醇注射液
Approval Number
国药准字H20234395
Approval Date
Oct 27, 2023
NMPA

Amlodipine Besilate and Benazepril Hydrochloride Capsules

Product Name
氨氯地平贝那普利胶囊
Approval Number
国药准字H20233691
Approval Date
Jun 7, 2023
NMPA

Fasudil Hydrochloride Injection

Product Name
盐酸法舒地尔注射液
Approval Number
国药准字H20183079
Approval Date
Mar 30, 2023
NMPA

Desloratadine Citrate Disodium Tablets

Product Name
枸地氯雷他定片
Approval Number
国药准字H20090138
Approval Date
Mar 20, 2023
NMPA

正元胶囊

Approval Number
国药准字Z20148001
Approval Date
Mar 20, 2023
NMPA

Neticonazole Hydrochloride Cream

Product Name
盐酸奈康唑乳膏
Approval Number
国药准字H20233067
Approval Date
Jan 19, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.